Charleston, SC -- (SBWIRE) -- 09/02/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock:- United Community Financial Corp (NASDAQ:UCFC), United Microelectronics Corp (ADR) (NYSE:UMC), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX),Mast Therapeutics Inc (NYSEMKT: MSTX)
United Community Financial Corp (NASDAQ:UCFC) ended its day with the loss of -6.28% and closed at the price of $4.03 after opening at $4.28. Stock traded during its last trading session with the total volume of 1.13 million shares, as compared to its average volume of 126,341.00 shares. United Community Financial Corp. (United Community) is a unitary thrift holding company for The Home Savings and Loan Company of Youngstown, Ohio (Home Savings or the Bank).
Has UCFC Found The Bottom and Ready To Move Up? Find Out Here
United Microelectronics Corp (ADR) (NYSE:UMC) stock traded during its last trading session with the total traded volume of 1.32 million shares, as compared to its average volume of 1.55 million shares. The company opened its shares at the price of $1.97 for the day and its closing price was $1.96 after gaining 1.03% for the day. United Microelectronics Corporation provides semiconductor wafer foundry solutions. The company offers wafer manufacturing services and other solutions to address the needs of foundry customers.
For How Long UMC Gloss will Attract Investors? Find out via this report
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) traded with volume of 1.11 million shares in the last session, as compared to average volume of 747,105.00 shares. The company started its trading session with the price of $2.55 and closed at $2.49 by scoring -2.35%. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Why Should Investors Buy LXRX After the Recent Fall? Just Go Here and Find Out
Mast Therapeutics Inc (NYSEMKT: MSTX) stock traded with total volume of 1.10 million shares, while the average trading volume remained 985,302.00 shares. MSTX started its trading session with the price of $0.43 and closed at $0.415 after declining -0.95%. Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. Its lead product candidate includes MST-188, a product candidate that has hemorheologic,
Will MSTX Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)